14 Million Euro Investment Boosts Domestic Pharmaceutical Machinery Industry
2 days ago
3,273
Despite a general slowdown in the machinery industry, the pharmaceutical machinery sector continues to grow, with a 6–7% annual increase expected through 2026. This trend is mirrored in Hungary, where a 14 million euro investment in Debrecen (eastern Hungary) is set to strengthen the domestic pharmaceutical machinery industry, Világgazdaság reports.
The global pharmaceutical market has experienced rapid growth since the early 2000s, reaching a value of 1.5 trillion US dollars in 2022. According to a study commissioned by the Hungarian Association of Pharmaceutical Manufacturers (MAGYOSZ), although the COVID-driven surge has subsided, long-term factors such as an aging population, recurring health crises, and increasing demand for new products continue to drive the pharmaceutical and related machinery sectors. Forecasts suggest an average annual growth of 5.3% in pharmaceutical machinery through 2026, while oncology products may grow by 11% annually until 2032.
Within this expanding market, Hungary’s pharmaceutical industry holds a strong position. In 2023, the sector generated 1,700 billion forints (4.2 billion euros) in sales, with 82% of production exported. Hungary ranks 20th in global pharmaceutical exports and an impressive 12th in per capita terms, KSH (Hungarian Statistical Office) data show.
The recent investment in Debrecen is a key development in Hungary.
German company Harro Höfliger acquired the Manz plant in the city for 8 million euros, and plans to invest an additional 14 million euros by 2026.
Related article
German Machinery Manufacturer to Open New Hall in Debrecen
The plant will manufacture fully assembled machines tailored to the needs of global pharmaceutical clients. According to Csaba Juhász, managing director of Harro Höfliger Hungary,
10 million euros worth of development will be completed this year, with the remaining 4 million euros allocated to technological upgrades in 2026.
The expansion will also double the plant’s workforce. Although the target of 450–500 employees is expected to be reached by the end of 2027, recruiting qualified staff remains a challenge due to the specialized skills required in pharmaceutical machinery manufacturing. To address this, Harro Höfliger has partnered with the University of Debrecen to support education and training efforts. The company views knowledge transfer as a priority in developing its team.
Additionally, Harro Höfliger aims to integrate the Debrecen facility into its global research and development network. The company already works closely with multinational pharmaceutical giants such as Pfizer and AstraZeneca and sees long-term potential in linking Debrecen’s production and R&D capacities to broader innovation efforts within the industry.
Related article
Pharmaceutical Company Contributes HUF 100 Million to Science Education
Gedeon Richter’s grant scheme offers schools the chance to expand their science education facilities.Continue reading
A legjobb élmény biztosítása érdekében olyan technológiákat használunk, mint a cookie-k az eszközadatok tárolására és/vagy eléréséhez. Ha beleegyezik ezekbe a technológiákba, akkor olyan adatokat dolgozhatunk fel ezen az oldalon, mint a böngészési viselkedés vagy az egyedi azonosítók. A hozzájárulás elmulasztása vagy visszavonása bizonyos funkciókat és funkciókat hátrányosan érinthet.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
